CS logo
small CS logo
Illinois CancerCare-Ottawa Clinic

Ottawa, Illinois, United States
Doctor in Ottawa, Illinois
1200 Starfire Dr, Ottawa, IL 61350

About Illinois CancerCare-Ottawa Clinic


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
172
SWOG Cancer Research Network
51
Alliance for Clinical Trials in Oncology
44
ECOG-ACRIN Cancer Research Group
24
NRG Oncology
8
Wake Forest University Health Sciences
7
GOG Foundation
6
Gynecologic Oncology Group
6
Children's Oncology Group
2
University of Rochester NCORP Research Base
2
Eastern Cooperative Oncology Group
1
Total Rows: 12

Clinical Trials at Illinois CancerCare-Ottawa Clinic


During the past decade, Illinois CancerCare-Ottawa Clinic conducted 182 clinical trials. In the 10-year time frame, 182 clinical trials started and 121 clinical trials were completed, i.e. on average, 66.5% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 65 clinical trials were completed. i.e. 104.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2020171723232424363635352222551212997712121616171721211717Started TrialsCompleted Trails20152016201720182019202020212022010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
2002-04-01
2014-02-01
Completed
58
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
2002-12-01
Completed
171
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
2003-06-01
2019-09-01
Completed
64
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Ixabepilone in Treating Patients With Metastatic Prostate Cancer
2004-09-01
2011-02-01
Completed
124
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144

Rows per page:

1–100 of 324

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Illinois CancerCare-Ottawa Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 172 trials, followed by "SWOG Cancer Research Network" with 51 trials sponsored, "Alliance for Clinical Trials in Oncology" with 44 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 24 trials sponsored and "NRG Oncology" with 24 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Ottawa Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 150 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 37 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 172National CancerInstitute (NCI): 172SWOG Cancer ResearchNetwork: 51SWOG Cancer ResearchNetwork: 51Alliance for ClinicalTrials in Oncology: 44Alliance for ClinicalTrials in Oncology: 44ECOG-ACRIN CancerResearch Group: 24ECOG-ACRIN CancerResearch Group: 24NRG Oncology: 8NRG Oncology: 8Wake Forest UniversityHealth Sciences: 7Wake Forest UniversityHealth Sciences: 7GOG Foundation: 6GOG Foundation: 6Gynecologic Oncology Group: 6Gynecologic Oncology Group: 6Children's Oncology Group: 2Children's Oncology Group: 2University of RochesterNCORP Research Base:2University of RochesterNCORP Research Base:2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 150National CancerInstitute (NCI): 150NRG Oncology: 30NRG Oncology: 30Canadian Cancer TrialsGroup: 12Canadian Cancer TrialsGroup: 12Cancer and LeukemiaGroup B: 6Cancer and LeukemiaGroup B: 6NCIC Clinical Trials Group: 6NCIC Clinical Trials Group: 6Eastern CooperativeOncology Group: 5Eastern CooperativeOncology Group: 5SWOG Cancer ResearchNetwork: 5SWOG Cancer ResearchNetwork: 5North Central CancerTreatment Group: 4North Central CancerTreatment Group: 4MillenniumPharmaceuticals, Inc.: 3MillenniumPharmaceuticals, Inc.: 3Radiation TherapyOncology Group: 2Radiation TherapyOncology Group: 2

Clinical Trials Conditions at Illinois CancerCare-Ottawa Clinic


According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Ottawa Clinic" are "Recurrent Breast Carcinoma" (11 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Ovarian Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Ottawa Clinic" in a lesser frequency.

Clinical Trials Intervention Types at Illinois CancerCare-Ottawa Clinic


Most popular intervention types in "Illinois CancerCare-Ottawa Clinic" are "Drug" (263 trials), "Other" (205 trials), "Biological" (129 trials), "Procedure" (84 trials) and "Radiation" (49 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (103 trials), "Quality-of-Life Assessment" (85 trials), "Questionnaire Administration" (57 trials), "Computed Tomography" (42 trials) and "Cisplatin" (41 trials). Other intervention names were less common.

Clinical Trials Genders at Illinois CancerCare-Ottawa Clinic


The vast majority of trials in "Illinois CancerCare-Ottawa Clinic" are 264 trials for "All" genders, 50 trials for "Female" genders and 10 trials for "Male" genders.

Clinical Trials Status at Illinois CancerCare-Ottawa Clinic


Currently, there are NaN active trials in "Illinois CancerCare-Ottawa Clinic". undefined are not yet recruiting, 91 are recruiting, 134 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 73 completed trials in Illinois CancerCare-Ottawa Clinic, 9 suspended trials, and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois CancerCare-Ottawa Clinic, 17 "Phase 1" clinical trials were conducted, 162 "Phase 2" clinical trials and 162 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 162Phase 2: 162Phase 3: 162Phase 3: 162Phase 1: 17Phase 1: 17Not Applicable: 8Not Applicable: 8Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 134Active, not recruiting: 134Recruiting: 91Recruiting: 91Completed: 73Completed: 73Terminated: 15Terminated: 15Suspended: 9Suspended: 9Unknown status: 2Unknown status: 2